
NEW YORK, Aug. 15, 2023 /PRNewswire/ -- The cell culture market is set to grow by USD 17.74 billion from 2022 to 2027 progressing at a CAGR of 11.3% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The high growth potential from emerging regions is notably driving the market growth. In developing regions, especially in countries such as India, China, and South Africa, cell culture technology has a high potential for growth. The cell culture market in emerging economies is growing rapidly, due to a number of factors. For example, Thermo Fisher Scientific is one company that is expanding its presence in emerging economies such as China, India, and the Middle East. The company is taking growth initiatives to increase its revenue from these regions. These initiatives are likely to increase awareness and adoption of advanced technologies such as cell culture in developing regions. This will lead to more vendors entering these markets, which will benefit the overall cell culture market. These factors will drive the global market growth during the forecast period. -Here is an Exclusive report talking about Market scenarios with a historical period (2017-2021) and the forecast period (2023-2027). Download Sample Report in minutes!
The cell culture market covers the following areas:
The report on the cell culture market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
Cell Culture Market 2023-2027 - Market Dynamics
The rising demand for monoclonal antibodies is an emerging trend in the market. Monoclonal antibodies are identical immune cells that are used in a wide range of applications, including biology, diagnostic imaging, medicine, and biochemistry. Thermo Fisher Scientific is one company that produces monoclonal antibodies. The company uses advanced cell culture platforms, single-use techniques, and a rapid test that detects viral or mycoplasma contamination. This ensures that the company produces high-quality, safe, and effective monoclonal antibodies. Thus, increasing demand for monoclonal antibodies is likely to increase the demand for cell culture consumables and equipment, which will positively impact the market growth.
The high cost of equipment challenges the cell culture market growth. The cost of consumables is comparatively less than the equipment. This includes CO2 inCubators, bioreactors, cryostorage systems, and biosafety cabinets. For example, the cost of a cryostorage freezer system is USD 25,000, and it is used for cell banking. In addition, the cost of a biosafety cabinet is more than USD 9,000. As the CO2 inCubator is a precision device required to maintain the gas level, a constant temperature and humidity in the room are essential. Hence, such challenges impede market growth during the forecast period.
What's New?
- Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
- Global competitiveness and key competitor positions
- Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - buy the report!
Cell Culture Market 2023-2027: Market Segmentation
This report extensively covers market segmentation by product (consumables and equipment), end-user (pharma and biotech companies, hospitals, research and academic institutes, and others), and geography (North America, Europe, Asia, and the Rest of the World). It also includes an in-depth analysis of drivers, trends, and challenges.
- The market share growth by the consumables segment will be significant during the forecast period. The consumables used in cell culture include sera, media, and reagents. This growth is because consumables are widely available, have a wide range of applications, and are used repeatedly. Since the demand for cell-based therapies and research increases, the demand for consumables increases. Vendors are responding to this demand by investing in research and development to develop new and improved cell media, reagents, and supplements. Therefore, as a result of the above-mentioned reasons, there will be a rise in this segment during the forecast period.
This report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters- View Sample Report
Companies Mentioned
- Agilent Technologies Inc.
- Avantor Inc.
- Becton Dickinson and Co.
- Bio Techne Corp.
- CLS Cell Lines Service GmbH
- Corning Inc.
- Danaher Corp.
- Eppendorf AG
- FUJIFILM Holdings Corp
- General Electric Co.
- InvivoGen
- LABGENE Scientific SA
- Lonza Group Ltd.
- Merck KGaA
- Miltenyi Biotec B.V. and Co. KG
- PromoCell GmbH
- Sartorius AG
- Sartorius CellGenix GmbH
- Thermo Fisher Scientific Inc.
- ZenBio Inc.
Company Offerings
- Agilent Technologies Inc. - The company offers cell culture products such as Seahorse XF cell culture plates.
- Becton Dickinson and Co. - The company offers cell culture products such as BD BACTEC Peds Plus medium and BD BACTEC Lytic Anaerobic medium.
- Bio Techne Corp. - The company offers cell culture products such as New ExCellerate iPSC Expansion Medium.
Gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Related Reports:
The cell culture consumables market size is estimated to grow at a CAGR of 22.3% between 2022 and 2027. The size of the cell culture market is forecast to increase by USD 23,729.7 million. This market report extensively covers market segmentation by application (biopharmaceutical production, cancer research, and others) and geography (North America, Europe, Asia, and the Rest of the World). The growing demand for monoclonal antibodies is notably driving market growth.
The 3D cell culture market share is expected to increase by USD 1.28 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 15.69%. This report extensively covers 3D cell culture market segmentation by application (cancer and stem cell research, drug discovery and toxicology testing, and tissue engineering and regenerative medicine) and geography (North America, Europe, Asia, and the Rest of World (ROW)). One of the key factors driving the global 3D cell culture market growth is the increase in infectious diseases.
Cell Culture Market Scope |
|
Report Coverage |
Details |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 11.3% |
Market growth 2023-2027 |
USD 17.74 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
10.61 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Agilent Technologies Inc., Avantor Inc., Becton Dickinson and Co., Bio Techne Corp., CLS Cell Lines Service GmbH, Corning Inc., Danaher Corp., Eppendorf AG, FUJIFILM Holdings Corp, General Electric Co., InvivoGen, LABGENE Scientific SA, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PromoCell GmbH, Sartorius AG, Sartorius CellGenix GmbH, Thermo Fisher Scientific Inc., and ZenBio Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Key Topics Covered:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 (USD billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 (USD billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global cell culture market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global cell culture market 2017 - 2021 (USD billion)
- 4.2 Product Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 (USD billion)
- 4.3 End-user Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 (USD billion)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 (USD billion)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 (USD billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
- 6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
- 6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product
- 6.3 Consumables - Market size and forecast 2022-2027
- Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 (USD billion)
- Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 (USD billion)
- Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
- 6.4 Equipment - Market size and forecast 2022-2027
- Exhibit 38: Chart on Equipment - Market size and forecast 2022-2027 (USD billion)
- Exhibit 39: Data Table on Equipment - Market size and forecast 2022-2027 (USD billion)
- Exhibit 40: Chart on Equipment - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Equipment - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product (USD billion)
7 Market Segmentation by End-user
- 7.1 Market segments
- Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
- 7.2 Comparison by End-user
- Exhibit 45: Chart on Comparison by End-user
- Exhibit 46: Data Table on Comparison by End-user
- 7.3 Pharma and biotech companies - Market size and forecast 2022-2027
- Exhibit 47: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 (USD billion)
- Exhibit 48: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 (USD billion)
- Exhibit 49: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
- Exhibit 50: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
- 7.4 Hospitals - Market size and forecast 2022-2027
- Exhibit 51: Chart on Hospitals - Market size and forecast 2022-2027 (USD billion)
- Exhibit 52: Data Table on Hospitals - Market size and forecast 2022-2027 (USD billion)
- Exhibit 53: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibit 54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
- 7.5 Research and academic Institutes - Market size and forecast 2022-2027
- Exhibit 55: Chart on Research and academic Institutes - Market size and forecast 2022-2027 (USD billion)
- Exhibit 56: Data Table on Research and academic Institutes - Market size and forecast 2022-2027 (USD billion)
- Exhibit 57: Chart on Research and academic Institutes - Year-over-year growth 2022-2027 (%)
- Exhibit 58: Data Table on Research and academic Institutes - Year-over-year growth 2022-2027 (%)
- 7.6 Others - Market size and forecast 2022-2027
- Exhibit 59: Chart on Others - Market size and forecast 2022-2027 (USD billion)
- Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 (USD billion)
- Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
- 7.7 Market opportunity by End-user
- Exhibit 63: Market opportunity by End-user (USD billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 65: Chart on Market share by geography 2022-2027 (%)
- Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 67: Chart on Geographic comparison
- Exhibit 68: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 69: Chart on North America - Market size and forecast 2022-2027 (USD billion)
- Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 (USD billion)
- Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 (USD billion)
- Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 (USD billion)
- Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 (USD billion)
- Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 (USD billion)
- Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 (USD billion)
- Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 (USD billion)
- Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 85: Chart on US - Market size and forecast 2022-2027 (USD billion)
- Exhibit 86: Data Table on US - Market size and forecast 2022-2027 (USD billion)
- Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 China - Market size and forecast 2022-2027
- Exhibit 89: Chart on China - Market size and forecast 2022-2027 (USD billion)
- Exhibit 90: Data Table on China - Market size and forecast 2022-2027 (USD billion)
- Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.9 Germany - Market size and forecast 2022-2027
- Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 (USD billion)
- Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 (USD billion)
- Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.10 Japan - Market size and forecast 2022-2027
- Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 (USD billion)
- Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 (USD billion)
- Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
- 9.11 UK - Market size and forecast 2022-2027
- Exhibit 101: Chart on UK - Market size and forecast 2022-2027 (USD billion)
- Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 (USD billion)
- Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 105: Market opportunity by geography (USD billion)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 106: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 108: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 109: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 110: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 111: Matrix on vendor position and classification
- 12.3 Agilent Technologies Inc.
- Exhibit 112: Agilent Technologies Inc. - Overview
- Exhibit 113: Agilent Technologies Inc. - Business segments
- Exhibit 114: Agilent Technologies Inc. - Key news
- Exhibit 115: Agilent Technologies Inc. - Key offerings
- Exhibit 116: Agilent Technologies Inc. - Segment focus
- 12.4 Becton Dickinson and Co.
- Exhibit 117: Becton Dickinson and Co. - Overview
- Exhibit 118: Becton Dickinson and Co. - Business segments
- Exhibit 119: Becton Dickinson and Co. - Key news
- Exhibit 120: Becton Dickinson and Co. - Key offerings
- Exhibit 121: Becton Dickinson and Co. - Segment focus
- 12.5 Bio Techne Corp.
- Exhibit 122: Bio Techne Corp. - Overview
- Exhibit 123: Bio Techne Corp. - Business segments
- Exhibit 124: Bio Techne Corp. - Key news
- Exhibit 125: Bio Techne Corp. - Key offerings
- Exhibit 126: Bio Techne Corp. - Segment focus
- 12.6 CLS Cell Lines Service GmbH
- Exhibit 127: CLS Cell Lines Service GmbH - Overview
- Exhibit 128: CLS Cell Lines Service GmbH - Product / Service
- Exhibit 129: CLS Cell Lines Service GmbH - Key offerings
- 12.7 Corning Inc.
- Exhibit 130: Corning Inc. - Overview
- Exhibit 131: Corning Inc. - Business segments
- Exhibit 132: Corning Inc. - Key news
- Exhibit 133: Corning Inc. - Key offerings
- Exhibit 134: Corning Inc. - Segment focus
- 12.8 Danaher Corp.
- Exhibit 135: Danaher Corp. - Overview
- Exhibit 136: Danaher Corp. - Business segments
- Exhibit 137: Danaher Corp. - Key news
- Exhibit 138: Danaher Corp. - Key offerings
- Exhibit 139: Danaher Corp. - Segment focus
- 12.9 Eppendorf AG
- Exhibit 140: Eppendorf AG - Overview
- Exhibit 141: Eppendorf AG - Product / Service
- Exhibit 142: Eppendorf AG - Key news
- Exhibit 143: Eppendorf AG - Key offerings
- 12.10 FUJIFILM Holdings Corp
- Exhibit 144: FUJIFILM Holdings Corp - Overview
- Exhibit 145: FUJIFILM Holdings Corp - Business segments
- Exhibit 146: FUJIFILM Holdings Corp - Key offerings
- Exhibit 147: FUJIFILM Holdings Corp - Segment focus
- 12.11 General Electric Co.
- Exhibit 148: General Electric Co. - Overview
- Exhibit 149: General Electric Co. - Business segments
- Exhibit 150: General Electric Co. - Key news
- Exhibit 151: General Electric Co. - Key offerings
- Exhibit 152: General Electric Co. - Segment focus
- 12.12 InvivoGen
- Exhibit 153: InvivoGen - Overview
- Exhibit 154: InvivoGen - Product / Service
- Exhibit 155: InvivoGen - Key offerings
- 12.13 LABGENE Scientific SA
- Exhibit 156: LABGENE Scientific SA - Overview
- Exhibit 157: LABGENE Scientific SA - Product / Service
- Exhibit 158: LABGENE Scientific SA - Key offerings
- 12.14 Lonza Group Ltd.
- Exhibit 159: Lonza Group Ltd. - Overview
- Exhibit 160: Lonza Group Ltd. - Business segments
- Exhibit 161: Lonza Group Ltd. - Key news
- Exhibit 162: Lonza Group Ltd. - Key offerings
- Exhibit 163: Lonza Group Ltd. - Segment focus
- 12.15 Merck KGaA
- Exhibit 164: Merck KGaA - Overview
- Exhibit 165: Merck KGaA - Business segments
- Exhibit 166: Merck KGaA - Key news
- Exhibit 167: Merck KGaA - Key offerings
- Exhibit 168: Merck KGaA - Segment focus
- 12.16 Sartorius CellGenix GmbH
- Exhibit 169: Sartorius CellGenix GmbH - Overview
- Exhibit 170: Sartorius CellGenix GmbH - Product / Service
- Exhibit 171: Sartorius CellGenix GmbH - Key news
- Exhibit 172: Sartorius CellGenix GmbH - Key offerings
- 12.17 Thermo Fisher Scientific Inc.
- Exhibit 173: Thermo Fisher Scientific Inc. - Overview
- Exhibit 174: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 175: Thermo Fisher Scientific Inc. - Key news
- Exhibit 176: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 177: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 178: Inclusions checklist
- Exhibit 179: Exclusions checklist
- 13.3 Currency conversion rates for USUSD
- Exhibit 180: Currency conversion rates for USUSD
- 13.4 Research methodology
- Exhibit 181: Research methodology
- Exhibit 182: Validation techniques employed for market sizing
- Exhibit 183: Information sources
- 13.5 List of abbreviations
- Exhibit 184: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
Share this article